 Bahram Salmanian
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta Accreta | 18 | 2023 | 29 | 6.420 |
Why?
| | Placenta Previa | 7 | 2022 | 10 | 2.020 |
Why?
| | Cesarean Section | 16 | 2023 | 230 | 1.790 |
Why?
| | Hysterectomy | 11 | 2022 | 137 | 1.290 |
Why?
| | Pregnancy | 42 | 2025 | 7197 | 1.150 |
Why?
| | Pre-Eclampsia | 4 | 2025 | 206 | 1.130 |
Why?
| | Ultrasonography, Prenatal | 7 | 2025 | 294 | 1.070 |
Why?
| | Umbilical Arteries | 2 | 2025 | 52 | 1.050 |
Why?
| | Fertilization in Vitro | 3 | 2021 | 93 | 0.920 |
Why?
| | Umbilical Veins | 1 | 2025 | 56 | 0.900 |
Why?
| | Ultrasonography, Doppler | 1 | 2025 | 126 | 0.860 |
Why?
| | Infant, Small for Gestational Age | 1 | 2025 | 117 | 0.840 |
Why?
| | Albuminuria | 1 | 2025 | 190 | 0.810 |
Why?
| | Fetal Growth Retardation | 2 | 2025 | 593 | 0.660 |
Why?
| | Fetal Diseases | 4 | 2015 | 194 | 0.640 |
Why?
| | Blood Transfusion | 3 | 2023 | 408 | 0.590 |
Why?
| | Placenta | 9 | 2023 | 784 | 0.550 |
Why?
| | Hydrothorax | 1 | 2014 | 3 | 0.410 |
Why?
| | Female | 45 | 2025 | 78763 | 0.410 |
Why?
| | Cardiac Tamponade | 1 | 2014 | 15 | 0.410 |
Why?
| | Fetofetal Transfusion | 3 | 2022 | 26 | 0.390 |
Why?
| | Postpartum Hemorrhage | 3 | 2023 | 28 | 0.370 |
Why?
| | Retrospective Studies | 22 | 2023 | 17269 | 0.370 |
Why?
| | Blood Component Transfusion | 3 | 2021 | 104 | 0.350 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2014 | 221 | 0.330 |
Why?
| | Humans | 45 | 2025 | 145491 | 0.290 |
Why?
| | Cohort Studies | 8 | 2025 | 5992 | 0.280 |
Why?
| | Iran | 3 | 2025 | 44 | 0.280 |
Why?
| | Pregnancy Outcome | 8 | 2022 | 497 | 0.260 |
Why?
| | Infant, Newborn | 10 | 2025 | 6437 | 0.240 |
Why?
| | Blood Loss, Surgical | 4 | 2019 | 112 | 0.230 |
Why?
| | Astigmatism | 2 | 2016 | 17 | 0.230 |
Why?
| | Sterilization, Tubal | 2 | 2015 | 17 | 0.230 |
Why?
| | Photorefractive Keratectomy | 2 | 2016 | 21 | 0.220 |
Why?
| | Adult | 24 | 2025 | 40707 | 0.220 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2023 | 437 | 0.220 |
Why?
| | Myopia | 2 | 2016 | 59 | 0.220 |
Why?
| | Social Justice | 2 | 2015 | 82 | 0.210 |
Why?
| | Nuchal Translucency Measurement | 2 | 2013 | 3 | 0.200 |
Why?
| | Laser Therapy | 2 | 2015 | 142 | 0.200 |
Why?
| | Creatinine | 1 | 2025 | 513 | 0.190 |
Why?
| | Delivery, Obstetric | 2 | 2016 | 161 | 0.190 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2023 | 69 | 0.180 |
Why?
| | Chorioamnionitis | 1 | 2022 | 50 | 0.180 |
Why?
| | Prenatal Diagnosis | 2 | 2021 | 196 | 0.180 |
Why?
| | Betamethasone | 2 | 2012 | 21 | 0.180 |
Why?
| | Apgar Score | 1 | 2021 | 21 | 0.170 |
Why?
| | Obstetric Labor, Premature | 2 | 2012 | 39 | 0.170 |
Why?
| | Incidence | 3 | 2025 | 2915 | 0.170 |
Why?
| | Obstetric Labor Complications | 1 | 2022 | 38 | 0.170 |
Why?
| | Erythrocyte Transfusion | 3 | 2019 | 227 | 0.170 |
Why?
| | Obstetrics | 1 | 2023 | 176 | 0.170 |
Why?
| | Heart Rate, Fetal | 1 | 2021 | 31 | 0.170 |
Why?
| | Urologic Diseases | 1 | 2021 | 40 | 0.170 |
Why?
| | Embryo Transfer | 1 | 2021 | 38 | 0.170 |
Why?
| | Labor, Obstetric | 1 | 2021 | 68 | 0.170 |
Why?
| | Gestational Age | 7 | 2022 | 988 | 0.160 |
Why?
| | Anemia | 1 | 2022 | 190 | 0.160 |
Why?
| | Intraoperative Complications | 1 | 2021 | 157 | 0.150 |
Why?
| | Premature Birth | 2 | 2022 | 387 | 0.150 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 2129 | 0.150 |
Why?
| | Hypocalcemia | 1 | 2019 | 39 | 0.140 |
Why?
| | Social Determinants of Health | 1 | 2023 | 308 | 0.140 |
Why?
| | Placenta, Retained | 2 | 2017 | 2 | 0.140 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 100 | 0.140 |
Why?
| | Fetoscopy | 2 | 2015 | 33 | 0.140 |
Why?
| | Placenta Diseases | 1 | 2018 | 20 | 0.130 |
Why?
| | Patient Care Team | 3 | 2019 | 696 | 0.130 |
Why?
| | Risk Factors | 7 | 2023 | 10874 | 0.130 |
Why?
| | Lasers, Excimer | 2 | 2016 | 30 | 0.130 |
Why?
| | Hydrops Fetalis | 1 | 2017 | 13 | 0.130 |
Why?
| | Severity of Illness Index | 2 | 2023 | 2945 | 0.130 |
Why?
| | Heart Defects, Congenital | 2 | 2017 | 909 | 0.130 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2017 | 43 | 0.130 |
Why?
| | Odds Ratio | 1 | 2020 | 1082 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2020 | 551 | 0.120 |
Why?
| | Infertility, Female | 1 | 2017 | 111 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1544 | 0.120 |
Why?
| | Vasa Previa | 1 | 2015 | 2 | 0.120 |
Why?
| | Prospective Studies | 3 | 2025 | 8039 | 0.110 |
Why?
| | Hemorrhage | 1 | 2021 | 826 | 0.110 |
Why?
| | Lymphatic Abnormalities | 1 | 2015 | 20 | 0.110 |
Why?
| | Interdisciplinary Communication | 1 | 2017 | 200 | 0.110 |
Why?
| | Renal Veins | 1 | 2015 | 18 | 0.110 |
Why?
| | Whooping Cough | 1 | 2015 | 55 | 0.110 |
Why?
| | Birth Weight | 4 | 2022 | 511 | 0.110 |
Why?
| | Tachycardia, Supraventricular | 1 | 2015 | 49 | 0.110 |
Why?
| | Young Adult | 8 | 2023 | 14192 | 0.110 |
Why?
| | Corneal Pachymetry | 1 | 2014 | 16 | 0.100 |
Why?
| | Treatment Outcome | 7 | 2018 | 11831 | 0.100 |
Why?
| | Hernia, Diaphragmatic | 1 | 2014 | 67 | 0.100 |
Why?
| | Biomarkers | 1 | 2025 | 4283 | 0.100 |
Why?
| | Fetal Therapies | 1 | 2014 | 47 | 0.100 |
Why?
| | Thyroxine | 1 | 2013 | 65 | 0.090 |
Why?
| | Clinical Protocols | 1 | 2014 | 282 | 0.090 |
Why?
| | Venous Thrombosis | 1 | 2015 | 194 | 0.090 |
Why?
| | Cornea | 1 | 2014 | 154 | 0.090 |
Why?
| | Placental Circulation | 1 | 2013 | 71 | 0.090 |
Why?
| | Pregnancy Trimester, First | 1 | 2013 | 138 | 0.090 |
Why?
| | Receptors, Opioid, mu | 1 | 2013 | 66 | 0.090 |
Why?
| | Cervix Uteri | 1 | 2012 | 50 | 0.090 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 478 | 0.090 |
Why?
| | Morphine | 1 | 2013 | 170 | 0.090 |
Why?
| | Uterine Cervical Diseases | 1 | 2011 | 6 | 0.080 |
Why?
| | Urinary Incontinence, Stress | 1 | 2010 | 15 | 0.080 |
Why?
| | Liver Diseases | 1 | 2014 | 304 | 0.080 |
Why?
| | Laparoscopy | 1 | 2015 | 481 | 0.080 |
Why?
| | Laser Coagulation | 2 | 2022 | 79 | 0.070 |
Why?
| | United States | 3 | 2022 | 16115 | 0.070 |
Why?
| | Pregnancy Complications | 2 | 2013 | 612 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 518 | 0.070 |
Why?
| | Fullerenes | 1 | 2008 | 11 | 0.070 |
Why?
| | Porphyrins | 1 | 2008 | 16 | 0.070 |
Why?
| | Magnetics | 1 | 2008 | 47 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2023 | 3619 | 0.070 |
Why?
| | Magnesium | 1 | 2008 | 156 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2013 | 894 | 0.070 |
Why?
| | Maternal Age | 2 | 2017 | 126 | 0.060 |
Why?
| | Cytokines | 2 | 2012 | 2054 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2019 | 2962 | 0.060 |
Why?
| | Adenosine Triphosphate | 1 | 2008 | 503 | 0.060 |
Why?
| | Pregnancy, Twin | 2 | 2016 | 19 | 0.060 |
Why?
| | Placentation | 2 | 2015 | 52 | 0.050 |
Why?
| | Pregnancy Trimester, Second | 2 | 2014 | 83 | 0.050 |
Why?
| | Myocardium | 1 | 2008 | 932 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 2002 | 0.050 |
Why?
| | Texas | 1 | 2023 | 273 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2013 | 4559 | 0.040 |
Why?
| | Nanoparticles | 1 | 2008 | 519 | 0.040 |
Why?
| | Cardiotocography | 1 | 2021 | 5 | 0.040 |
Why?
| | Child | 1 | 2022 | 22680 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 2021 | 81 | 0.040 |
Why?
| | Acidosis | 1 | 2021 | 105 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2017 | 5891 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2883 | 0.040 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2019 | 33 | 0.040 |
Why?
| | Iron | 1 | 2022 | 359 | 0.040 |
Why?
| | Family | 1 | 2023 | 687 | 0.040 |
Why?
| | Platelet Transfusion | 1 | 2019 | 78 | 0.030 |
Why?
| | Perinatal Mortality | 1 | 2017 | 23 | 0.030 |
Why?
| | Plasma | 1 | 2019 | 225 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2017 | 42 | 0.030 |
Why?
| | Breech Presentation | 1 | 2016 | 1 | 0.030 |
Why?
| | Refraction, Ocular | 1 | 2016 | 47 | 0.030 |
Why?
| | Emergencies | 1 | 2017 | 175 | 0.030 |
Why?
| | Polyhydramnios | 1 | 2015 | 17 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2016 | 5426 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 114 | 0.030 |
Why?
| | Fetal Death | 1 | 2014 | 58 | 0.030 |
Why?
| | Morbidity | 1 | 2015 | 322 | 0.030 |
Why?
| | Twins, Monozygotic | 1 | 2014 | 134 | 0.030 |
Why?
| | Abortion, Eugenic | 1 | 2013 | 3 | 0.030 |
Why?
| | Karyotype | 1 | 2013 | 19 | 0.020 |
Why?
| | Thyroid Function Tests | 1 | 2013 | 19 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3424 | 0.020 |
Why?
| | Nitrites | 1 | 2013 | 89 | 0.020 |
Why?
| | Prenatal Care | 1 | 2015 | 312 | 0.020 |
Why?
| | Hypothyroidism | 1 | 2013 | 67 | 0.020 |
Why?
| | Thyrotropin | 1 | 2013 | 119 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2130 | 0.020 |
Why?
| | Nitrates | 1 | 2013 | 100 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2013 | 234 | 0.020 |
Why?
| | Rats | 2 | 2013 | 5581 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2017 | 693 | 0.020 |
Why?
| | Tomography, Optical Coherence | 1 | 2014 | 271 | 0.020 |
Why?
| | Reference Values | 1 | 2013 | 797 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 784 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 193 | 0.020 |
Why?
| | Renal Insufficiency | 1 | 2013 | 172 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2013 | 204 | 0.020 |
Why?
| | Parity | 1 | 2010 | 109 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4323 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 848 | 0.020 |
Why?
| | Fetal Development | 1 | 2013 | 297 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 505 | 0.020 |
Why?
| | Interleukins | 1 | 2011 | 249 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 821 | 0.020 |
Why?
| | Middle Aged | 3 | 2017 | 36176 | 0.020 |
Why?
| | Neutron Diffraction | 1 | 2008 | 3 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 616 | 0.020 |
Why?
| | Scattering, Small Angle | 1 | 2008 | 22 | 0.020 |
Why?
| | Isotopes | 1 | 2008 | 34 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1348 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2008 | 157 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2008 | 132 | 0.020 |
Why?
| | Postpartum Period | 1 | 2010 | 373 | 0.020 |
Why?
| | Drug Discovery | 1 | 2008 | 154 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2526 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2008 | 449 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2008 | 563 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1212 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2011 | 2060 | 0.010 |
Why?
| | Kidney | 1 | 2013 | 1498 | 0.010 |
Why?
| | Heart | 1 | 2008 | 626 | 0.010 |
Why?
| | Time Factors | 1 | 2015 | 7171 | 0.010 |
Why?
| | Oxygen | 1 | 2008 | 986 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3897 | 0.010 |
Why?
| | Adolescent | 2 | 2012 | 22485 | 0.010 |
Why?
| | Mitochondria | 1 | 2008 | 990 | 0.010 |
Why?
| | Hypoxia | 1 | 2008 | 1199 | 0.010 |
Why?
| | Animals | 2 | 2013 | 38141 | 0.010 |
Why?
| | Male | 2 | 2014 | 72817 | 0.010 |
Why?
|
|
Salmanian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|